Featured Article: Curcumin: the spicy modulator of breast carcinogenesis
Despite best efforts, a cure for breast cancer remains yet to be discovered. However, advances in treatment and prevention are making great progress in breast cancer research. Over the years, naturally-sourced products are becoming increasingly popular in breast cancer therapy and prevention. Curcumin is the main component of turmeric, a spice derived from the ginger plant family. Historically, curcumin has been used as a homemade remedy for a variety of medical complaints, however in recent years, the role of curcumin as a promising natural anticancer agent has been of particular interest.
In this review, U Banik et al., highlight the effects that curcumin can have on breast carcinogenesis and discuss the potential for this natural product to play a major role in breast cancer research.
Click here to access the full article.
Click here to access all of the reviews published to date in JECCR.
Published on: 15 September 2017
Published on: 13 September 2017
ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population
Published on: 11 September 2017
Aims and scope
JECCR is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.
Manuscript turnaround times
Following rigorous peer review of a manuscript, authors can expect to receive a first decision within 30 days.
JECCR now welcomes submissions of commentaries that either discuss recently published research or covers an aspect of a issue relevant to the journal's scope.
JECCR has been publishing since 1982. Prior to 2008, JECCR was published in print. For enquiries about previous content, please contact us.